J.P. Mariwell Inc. signed a letter agreement to acquire Mesa Exploration Corp. (TSXV:MSA) in a reverse merger transaction on December 20, 2017. Under the terms, Mesa Exploration will issue 172 million shares to the JPM shareholders. These shares will be issued in tranches triggered by various approvals granted by Health Canada to JPM under the ACMPR. In a separate transaction, JPM and Mesa also agreed to raise up to CAD 2 million via private placement. After the completion of the transaction, Mesa Exploration will be involved in the Life Sciences industry sector. Foster Wilson, President, Chief Executive Officer and Director of Mesa, Joe Chan, Chief Financial Officer of Mesa, Greg French, Director of Mesa, Brian Kirwin, Non-Executive Chairman and Director of Mesa and Larry Kornze, Director of Mesa Exploration will be principals or Insiders of the resulting issuer. Paul Greco, President of JPM, Patrick Weaver, Vice President of JPM, Nicholas Jacobs, Sole Director of JPM, Amy Jacobs, Co-Founder of JPM and Frankie Jacobs, Co-Founder of JPM will be principals or Insiders of the resulting issuer. The transaction is subject to customary closing conditions, including exchange approval, applicable director and shareholder approvals, satisfaction with diligence investigations, entering into applicable definitive agreement and necessary corporate approvals. As of February 2, 208, Mesa Exploration agreed to an extension of the letter agreement wherein the time required and agreed to complete certain actions and events has been extended to February 16, 2018.